Hepatitis B drugs in development
1 July 2010. Related: Pipeline report, Hepatitis coinfection.
2010
Hepatitis C treatment pipeline
1 July 2010. Related: Pipeline report, Hepatitis coinfection.
Tuberculosis pipeline introduction
1 July 2010. Related: Pipeline report, TB coinfection.
Tuberculosis diagnostic pipeline
1 July 2010. Related: Pipeline report, TB coinfection.
Tuberculosis treatment pipeline
1 July 2010. Related: Special reports, TB coinfection.
Tuberculosis vaccine pipeline
1 July 2010. Related: Special reports, TB coinfection.
2010 pipeline report PDF
1 July 2010. Related: Pipeline report, PDFs.
Volume 11 Number 5/6 May/June 2010
1 June 2010. Related: Editorial.
2nd Joint Conference of BHIVA with BASHH, 20-23 April 2010, Manchester
1 June 2010. Related: Conference reports.
HAART use among women in UK receiving treatment prior to conception
1 June 2010. Related: Conference reports, Pregnancy.
Duration of ruptured membranes and vertical transmission in the UK
1 June 2010. Related: Conference reports, Pregnancy.
Significant rates of unplanned pregnancies among young women born with HIV
1 June 2010. Related: Conference reports, Pregnancy, Paediatric care.
Route of HCV transmission in HIV-positive gay men is unlikely to be from semen
1 June 2010. Related: Conference reports, Hepatitis coinfection.
75% HIV-positive children have insufficient levels of Vitamin D
1 June 2010. Related: Conference reports, Paediatric care, Side effects, Lipodystrophy and metabolic complications.
Increase in LGV cases in gay men reported in the UK
1 June 2010. Related: Conference reports.
High rates of osteopenia and osteoporosis: importance of DEXA monitoring
1 June 2010. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Summaries of other studies
1 June 2010. Related: Conference reports, HIV prevention and transmission.
11th International Workshop on Clinical Pharmacology of HIV Therapy, 7-9 April, 2010, Sorrento, Italy
1 June 2010. Related: Conference reports, PK and drug interactions.
Atazanavir absorption maximised with food
1 June 2010. Related: Conference reports, PK and drug interactions.
Methadone levels reduced moderately by rilpivirine
1 June 2010. Related: Conference reports, PK and drug interactions.
Maraviroc 150mg once-daily achieves target concentrations with atazanavir/ritonavir
1 June 2010. Related: Conference reports, PK and drug interactions.
Raltegravir and unboosted atazanavir
1 June 2010. Related: Conference reports, PK and drug interactions.
Raltegravir dose adjustment not required for patients on dialysis
1 June 2010. Related: Conference reports, PK and drug interactions.
Raltegravir and darunavir pharmacokinetics in liver disease
1 June 2010. Related: Conference reports, PK and drug interactions.
Tenofovir may require closer renal monitoring in older patients
1 June 2010. Related: Conference reports, PK and drug interactions, Injecting drug users.
Effect of age on atazanavir, darunavir, raltegravir and etravirine
1 June 2010. Related: Conference reports, PK and drug interactions.
Proposed approach to measuring TDM for raltegravir
1 June 2010. Related: Conference reports, PK and drug interactions.
Increased bilirubin levels when atazanavir is dosed twice-daily
1 June 2010. Related: Conference reports, PK and drug interactions.
17th Conference on Retroviruses and Opportunistic Infections (CROI) 16-19 February 2010, San Francisco
1 June 2010. Related: Conference reports.
HIV reinfection cases reported at CROI
1 June 2010. Related: Conference reports, HIV prevention and transmission, Virology.
Hepatitis studies: IL28B genetics, HCV survival, FibroScan in acute HCV, MSM reinfection and responses to transplantation
1 June 2010. Related: Conference reports, Hepatitis coinfection.
Poor bioequivalence with crushed and dissolved tablets
1 June 2010. Related: Conference reports, Paediatric care, PK and drug interactions.
Initial PK, safety and 12 week efficacy of raltegravir chewable tablets in children 6-11 years
1 June 2010. Related: Conference reports, Paediatric care.
PK of efavirenz in children dosed according to WHO weight bands
1 June 2010. Related: Conference reports, Paediatric care.
Virological and immunological responses in infants enrolled in the CHER trial
1 June 2010. Related: Conference reports, Paediatric care.
Darunavir-associated mutations in PI-naive and PI-experienced children in the UK
1 June 2010. Related: Conference reports, Paediatric care, Drug resistance.
HIV persistence, raltegravir/maraviroc intensification and immunology
1 June 2010. Related: Conference reports, Basic science and immunology.
START study launched and endorsed by broad community support: over 140 community organisations sign letter to US guideline panel
1 June 2010. Related: Antiretrovirals.
FDA safety updates to antiretroviral labels
1 June 2010. Related: Antiretrovirals.
Development of apricitabine halted without finding backer for Phase 3
1 June 2010. Related: Antiretrovirals.
FDA approval of generic ARVs
1 June 2010. Related: Treatment access.
U.S. government leading backlash against AIDS funding
1 June 2010. Related: Treatment access.
Evidence from six countries confirms fears of People Living With HIV/AIDS: treatment rationing is escalating
1 June 2010. Related: Treatment access, Treatment advocacy.
Launch of the 10th funding round and other outcomes from the Global Fund
1 June 2010. Related: Treatment access.
Pregnancy outcomes with efavirenz
1 June 2010. Related: Pregnancy.
The antiviral impact of CD8 T cells: much ado about the mechanism
1 June 2010. Related: Basic science and immunology.
Bad to the bone marrow?
1 June 2010. Related: Basic science and immunology.
Cell-free vs cell-associated HIV transmission
1 June 2010. Related: Basic science and immunology.
Coagulation and inflammatory biomarkers in children and adolescents with HIV
1 June 2010. Related: Basic science and immunology.
Pre-infection CD8 T cells targeting HIV linked to lower post-infection viral load
1 June 2010. Related: Basic science and immunology.
The HIV Research Catalyst Forum: treatment, prevention, advocacy
1 June 2010. Related: Treatment advocacy.
Experimental HCV drugs for HIV/HCV coinfected people: workshop on trial design
1 June 2010. Related: Treatment advocacy.
AIDS activists detained by Tanzanian authorities at World Economic Forum on Africa
1 June 2010. Related: Treatment advocacy.
China lifts travel ban on people with HIV
1 June 2010. Related: Other news.
Malawian courts 14-year sentence for gay men widely condemned
1 June 2010. Related: Other news.
Uganda law proposes death penalty for homosexuality: can international reaction and vulnerability of treatment access programmes help?
1 June 2010. Related: Other news.
Volume 11 Number 3/ May/April 2010 PDF
1 June 2010. Related: PDFs.
Volume 11 Number 3/4 March/April 2010
2 April 2010. Related: Editorial.
17th Conference on Retroviruses and Opportunistic Infections (CROI), 16-19 February 2010, San Francisco
2 April 2010. Related: Conference reports.
Treatment reduces infections by over 90%: a theme that is here to stay
2 April 2010. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
ACTG 5205: atazanavir/ritonavir vs efavirenz in treatment naive patients
2 April 2010. Related: Conference reports, Antiretrovirals, Side effects, Lipodystrophy and metabolic complications.
Pipeline compounds and new approaches to treatment
2 April 2010. Related: Conference reports, Antiretrovirals.
Clinical benefits of stopping smoking: CVD and CHD risk returns to that of previous smoker in HIV-positive people within three years
2 April 2010. Related: Conference reports, Lipodystrophy and metabolic complications, Cancer and HIV.
HIV increases the risk of lung cancer, independent of smoking status
2 April 2010. Related: Conference reports, Cancer and HIV.
HIV positive people in the HOPS cohort have 4-fold risk of fracture compared to general population in the US
2 April 2010. Related: Conference reports, Side effects.